Detailed Information
Cited 62 time in 
Cited 69 time in 
Cited 69 time in
Metadata Downloads
Updated guidance on the management of COVID-19: From an american thoracic society/european respiratory society coordinated international task force (29 July 2020)
- Authors
- Bai, C.[Bai, C.]; Chotirmall, S.H.[Chotirmall, S.H.]; Rello, J.[Rello, J.]; Alba, G.A.[Alba, G.A.]; Ginns, L.C.[Ginns, L.C.]; Krishnan, J.A.[Krishnan, J.A.]; Rogers, R.[Rogers, R.]; Bendstrup, E.[Bendstrup, E.]; Burgel, P.-R.[Burgel, P.-R.]; Chalmers, J.D.[Chalmers, J.D.]; Chua, A.[Chua, A.]; Crothers, K.A.[Crothers, K.A.]; Duggal, A.[Duggal, A.]; Kim, Y.W.[Kim, Y.W.]; Laffey, J.G.[Laffey, J.G.]; Luna, C.M.[Luna, C.M.]; Niederman, M.S.[Niederman, M.S.]; Raghu, G.[Raghu, G.]; Ramirez, J.A.[Ramirez, J.A.]; Riera, J.[Riera, J.]; Roca, O.[Roca, O.]; Tamae-Kakazu, M.[Tamae-Kakazu, M.]; Torres, A.[Torres, A.]; Watkins, R.R.[Watkins, R.R.]; Barrecheguren, M.[Barrecheguren, M.]; Belliato, M.[Belliato, M.]; Chami, H.A.[Chami, H.A.]; Chen, R.[Chen, R.]; Cortes-Puentes, G.A.[Cortes-Puentes, G.A.]; Delacruz, C.[Delacruz, C.]; Hayes, M.M.[Hayes, M.M.]; Heunks, L.M.A.[Heunks, L.M.A.]; Holets, S.R.[Holets, S.R.]; Hough, C.L.[Hough, C.L.]; Jagpal, S.[Jagpal, S.]; Jeon, K.[Jeon, K.]; Johkoh, T.[Johkoh, T.]; Lee, M.M.[Lee, M.M.]; Liebler, J.[Liebler, J.]; McElvaney, G.N.[McElvaney, G.N.]; Moskowitz, A.[Moskowitz, A.]; Oeckler, R.A.[Oeckler, R.A.]; Ojanguren, I.[Ojanguren, I.]; O’regan, A.[O’regan, A.]; Pletz, M.W.[Pletz, M.W.]; Rhee, C.K.[Rhee, C.K.]; Schultz, M.J.[Schultz, M.J.]; Storti, E.[Storti, E.]; Strange, C.[Strange, C.]; Thomson, C.C.[Thomson, C.C.]; Torriani, F.J.[Torriani, F.J.]; Wang, X.[Wang, X.]; Wuyts, W.[Wuyts, W.]; Xu, T.[Xu, T.]; Yang, D.[Yang, D.]; Zhang, Z.[Zhang, Z.]; Wilson, K.C.[Wilson, K.C.]
- Issue Date
- 30-Sep-2020
- Publisher
- European Respiratory Society
- Citation
- European Respiratory Review, v.29, no.157, pp.1 - 15
- Indexed
- SCIE
SCOPUS
- Journal Title
- European Respiratory Review
- Volume
- 29
- Number
- 157
- Start Page
- 1
- End Page
- 15
- ISSN
- 0905-9180
- Abstract
- Background: Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome-coronavirus-2. Consensus suggestions can standardise care, thereby improving outcomes and facilitating future research. Methods: An International Task Force was composed and agreement regarding courses of action was measured using the Convergence of Opinion on Recommendations and Evidence (CORE) process. 70% agreement was necessary to make a consensus suggestion. Results: The Task Force made consensus suggestions to treat patients with acute COVID-19 pneumonia with remdesivir and dexamethasone but suggested against hydroxychloroquine except in the context of a clinical trial; these are revisions of prior suggestions resulting from the interim publication of several randomised trials. It also suggested that COVID-19 patients with a venous thromboembolic event be treated with therapeutic anticoagulant therapy for 3 months. The Task Force was unable to reach sufficient agreement to yield consensus suggestions for the post-hospital care of COVID-19 survivors. The Task Force fell one vote shy of suggesting routine screening for depression, anxiety and post-traumatic stress disorder. Conclusions: The Task Force addressed questions related to pharmacotherapy in patients with COVID-19 and the post-hospital care of survivors, yielding several consensus suggestions. Management options for which there is insufficient agreement to formulate a suggestion represent research priorities. © ERS 2020.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- JEON, KYEONG MAN
- Medicine (Medicine)